$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in INTERCEPT PHARMACEUTICALS, INC. for free.

CIK Number: 0001270073
IRS Number: 223868459
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ICPT
Company Address: 10 HUDSON YARDS, 37TH FLOOR NEW YORK 10001
Phone number: 646-747-1000
Former name: INTERCEPT PHARMACEUTICALS INC, date of change: 2003-11-13

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Market Capitalization: $2.80B
Prev close: $113.57
Average Daily Volume: 475,158
Days Low: $110.70
Year Low: $89.76
Year High: $177.93

INTERCEPT PHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
AKKARAJU SRINIVASDirector477,12954,187,541shares bought: 676,705 / shares sold: -23,438 STRONG BUYMar 12 20212 months ago
Cawkwell GailSVP, Med Affairs, Safety & PV32,8723,733,273shares bought: 22,784 / shares sold: -3,882 STRONG BUYFeb 17 20213 months ago
Durso Jerome BenedictPresident & CEO82,1429,328,867shares bought: 94,600 / shares sold: -7,401 STRONG BUYApr 05 20211 month ago
Ford David AChief Human Resources Officer23,7112,692,858shares bought: 29,200 / shares sold: -3,609 STRONG BUYMay 11 2021yesterday
Pruzanski MarkDirector506,46657,519,344shares bought: 267,940 / shares sold: -216,611 BUYMay 04 20218 days ago
Richardson Linda MEVP & Chief Commercial Officer26,8663,051,172shares bought: 5,531 / shares sold: 0 BUYFeb 17 20213 months ago
Venezia RoccoChief Accounting Officer14,2891,622,802shares bought: 0 / shares sold: -29 STRONG SELLApr 05 20211 month ago
Weyer ChristianEVP, Research & Development27,3413,105,117shares bought: 47,825 / shares sold: -20,879 STRONG BUYApr 05 20211 month ago

View all INTERCEPT PHARMACEUTICALS, INC. insiders.

INTERCEPT PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 11 2021ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF17.151282,19523,71123.8 K to 23.7 K (-0.54 %)
May 04 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorPayment of ExerciseF19.783,81775,500502,649506.5 K to 502.6 K (-0.75 %)
May 04 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorGrantA19.786,138121,410506,466500.3 K to 506.5 K (+1.23 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF24.28461,11727,34127.4 K to 27.3 K (-0.17 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Venezia RoccoChief Accounting Of ...Payment of ExerciseF24.282970414,28914.3 K to 14.3 K (-0.20 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF24.28922,23423,83923.9 K to 23.8 K (-0.38 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Durso Jerome BenedictPresident & CEOPayment of ExerciseF24.282897,01782,14282.4 K to 82.1 K (-0.35 %)
Apr 01 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorPayment of ExerciseF23.083,65884,427500,328504 K to 500.3 K (-0.73 %)
Apr 01 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorGrantA23.086,136141,619503,986497.9 K to 504 K (+1.23 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.29147,0003,129,630640,688493.7 K to 640.7 K (+29.78 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.5516,559356,846493,688477.1 K to 493.7 K (+3.47 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP20.8373,4411,529,776477,129403.7 K to 477.1 K (+18.19 %)
Feb 25 2021ICPTINTERCEPT PHARMACE ...Durso Jerome BenedictPresident & CEOPayment of ExerciseF28.123198,97082,43182.8 K to 82.4 K (-0.39 %)
Feb 17 2021ICPTINTERCEPT PHARMACE ...Richardson Linda MEVP & Chief Commerc ...Option ExerciseA31.328,500266,2208,500
Feb 17 2021ICPTINTERCEPT PHARMACE ...Richardson Linda MEVP & Chief Commerc ...GrantA0.005,531026,86621.3 K to 26.9 K (+25.92 %)

View all INTERCEPT PHARMACEUTICALS, INC. insider transactions.